CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 168 filers reported holding CLOVIS ONCOLOGY INC in Q1 2021. The put-call ratio across all filers is 1.19 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $26,000 | -27.8% | 13,111 | 0.0% | 0.00% | – |
Q4 2021 | $36,000 | -37.9% | 13,111 | 0.0% | 0.00% | – |
Q3 2021 | $58,000 | -23.7% | 13,111 | 0.0% | 0.00% | – |
Q2 2021 | $76,000 | -17.4% | 13,111 | 0.0% | 0.00% | -100.0% |
Q1 2021 | $92,000 | +46.0% | 13,111 | 0.0% | 0.00% | – |
Q4 2020 | $63,000 | -17.1% | 13,111 | 0.0% | 0.00% | -100.0% |
Q3 2020 | $76,000 | -13.6% | 13,111 | 0.0% | 0.00% | 0.0% |
Q2 2020 | $88,000 | +700.0% | 13,111 | +376.1% | 0.00% | – |
Q3 2019 | $11,000 | -73.2% | 2,754 | 0.0% | 0.00% | – |
Q2 2019 | $41,000 | -39.7% | 2,754 | 0.0% | 0.00% | -100.0% |
Q1 2019 | $68,000 | +21.4% | 2,754 | -12.4% | 0.00% | 0.0% |
Q4 2018 | $56,000 | -39.1% | 3,144 | 0.0% | 0.00% | 0.0% |
Q3 2018 | $92,000 | -22.0% | 3,144 | +21.2% | 0.00% | 0.0% |
Q2 2018 | $118,000 | -13.9% | 2,595 | 0.0% | 0.00% | 0.0% |
Q1 2018 | $137,000 | -22.2% | 2,595 | 0.0% | 0.00% | -50.0% |
Q4 2017 | $176,000 | +17.3% | 2,595 | +42.7% | 0.00% | +100.0% |
Q3 2017 | $150,000 | -11.8% | 1,819 | 0.0% | 0.00% | -50.0% |
Q2 2017 | $170,000 | +46.6% | 1,819 | 0.0% | 0.00% | +100.0% |
Q1 2017 | $116,000 | +146.8% | 1,819 | +71.4% | 0.00% | – |
Q4 2016 | $47,000 | +23.7% | 1,061 | 0.0% | 0.00% | – |
Q3 2016 | $38,000 | +322.2% | 1,061 | +56.5% | 0.00% | – |
Q2 2016 | $9,000 | -30.8% | 678 | 0.0% | 0.00% | – |
Q1 2016 | $13,000 | -45.8% | 678 | 0.0% | 0.00% | – |
Q4 2015 | $24,000 | -40.0% | 678 | +55.1% | 0.00% | -100.0% |
Q3 2015 | $40,000 | +400.0% | 437 | +391.0% | 0.00% | – |
Q2 2015 | $8,000 | +14.3% | 89 | 0.0% | 0.00% | – |
Q1 2015 | $7,000 | – | 89 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |